Globus Medical (NYSE:GMED) shares traded down after the U.S. Food and Drug Administration (FDA) issued a warning letter to the company CEO, Daniel Scavilla, citing violations related to MedTech ...

But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 2 warning signs for Globus Medical you should be aware of.